SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eisai Inc. Divests U.S. Rights for GLIADEL® Wafer (Polifeprosan 20 With Carmustine Implant) to Arbor Pharmaceuticals